AZITHROMYCIN | A207531 | EPIC PHARMA LLC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| D. Del. | 2017-07-19 | Terminated 2017-10-05 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.3923
per ml
Lowest NADAC/Unit
$0.2140
per ml
Brand NDCs
0
Generic NDCs
7
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 42806014731AZITHROMYCIN 100 MG/5 ML SUSP | $0.3923 | ML | Generic | — | 2026-06-17 |
| 24658070632AZITHROMYCIN 200 MG/5 ML SUSP | $0.3266 | ML | Generic | — | 2026-06-17 |
| 42806014932AZITHROMYCIN 200 MG/5 ML SUSP | $0.3266 | ML | Generic | — | 2026-06-17 |
| 24658070733AZITHROMYCIN 200 MG/5 ML SUSP | $0.2385 | ML | Generic | — | 2026-06-17 |
| 42806015033AZITHROMYCIN 200 MG/5 ML SUSP | $0.2385 | ML | Generic | — | 2026-06-17 |
| 24658070834AZITHROMYCIN 200 MG/5 ML SUSP | $0.2140 | ML | Generic | — | 2026-06-17 |
| 42806015134AZITHROMYCIN 200 MG/5 ML SUSP | $0.2140 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.